Selective inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17βHSD1) reduces estrogen responsive cell growth of T47-D breast cancer cells-Reference-Cited by-同舟云学术

Selective inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17βHSD1) reduces estrogen responsive cell growth of T47-D breast cancer cells

Published:2009-04 Issue:3-5 Volume:114 Page:200-206
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Kruchten Patricia,Werth Ruth,Bey Emmanuel,Oster Alexander,Marchais-Oberwinkler Sandrine,Frotscher Martin,Hartmann Rolf W.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference47 articles.

1. Do hormones cause breast cancer?;Thomas;Cancer,1984

2. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group;Cauley;Ann. Intern. Med.,1999

3. 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells;Russo;FASEB J.,2006

4. Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression;Dizerega;Fertil. Steril.,1980

5. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol;Zeitoun;J. Clin. Endocrinol. Metab.,1998

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model;Journal of Medicinal Chemistry;2023-06-27

2. Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis;Journal of Medicinal Chemistry;2022-08-22

3. Synthesis of 1,4-Biphenyl-triazole Derivatives as Possible 17β-HSD1 Inhibitors: An in Silico Study;ACS Omega;2020-06-01

4. Development of potential preclinical candidates with promising in vitro ADME profile for the inhibition of type 1 and type 2 17β-Hydroxysteroid dehydrogenases: Design, synthesis, and biological evaluation;European Journal of Medicinal Chemistry;2019-09

5. Inhibitors of 17β-hydroxysteroid dehydrogenase type 1, 2 and 14: Structures, biological activities and future challenges;Molecular and Cellular Endocrinology;2019-06